Frontiers in Immunology is a peer-reviewed Open Access Journal, and the official Journal of theInternational Union of Immunological Societies (IUIS). It provides a novel way to disseminate the latest findings in basic and translational research in Immunology and to facilitate communication, both among scientists as well as the community at large.
Frontiers in Immunology aims to publish the most outstanding research findings encompassing the entire field of Immunology. In addition to papers that investigate basic mechanisms of immune system development and function, a particular emphasis is given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. Furthermore, availability of a growing number of biological drugs, coupled with fine characterization of the molecular mechanisms of disease, has now made precision medicine a desirable approach for many immunological disorders. Frontiers in Immunology intends to portray how advances of scientific knowledge and technology may translate into novel approaches to diagnosis and treatment of immune disorders, both in animal and cellular models and in humans.
All manuscripts submitted to Frontiers in Immunology that report on studies conducted in human subjects must conform with current regulation and the Declaration of Helsinki, and must receive approval from the Institutional Review Board and patient informed consent. Animal welfare and Ethics Committee approval is required for studies involving animals.
Frontiers in Immunology is organized into Specialty Sections that cover different areas of research in Immunology. Authors should refer to the author guidelines for details on article types and the submission process.